DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 7th, 2017 • AntriaBio, Inc. • Pharmaceutical preparations • Delaware
This Development and License Agreement (this “Agreement”), dated as of August 4, 2017 (the “Effective Date”), is by and between ActiveSite Pharmaceuticals, Inc., a Delaware corporation with its principal office located at 187 Magellan Avenue, San Francisco, California 94116 (“ActiveSite”), and AntriaBio, Inc., a Delaware corporation with its principal office located at 1450 Infinite Drive, Louisville, CO 80027 (“AntriaBio”), each a “Party” and collectively “Parties”.
